Literature DB >> 24887481

Activated protease receptor-2 induces GATA6 expression to promote survival in irradiated colon cancer cells.

Wen-song Cai1, Fei Shen1, Jiang-lin Li1, Zhe Feng1, Ying-cheng Wang1, Huan-qing Xiao1, Bo Xu2.   

Abstract

BACKGROUND AND AIMS: The resistance to irradiation is common and a great drawback in the treatment of cancer with radiotherapy; the underlying mechanism is unclear. GATA binding protein 6 (GATA6) is associated with the pathogenesis of cancer. This study aims to investigate the role of GATA6 on compromising irradiation effect on HT55 and HT29 cells, 2 colorectal cancer cell lines.
METHODS: Human colon cancer cell lines, HT55 and HT29 cells, were treated with irradiation in the culture. Apoptosis of HT55 and HT29 cells was determined by flow cytometry. The expression of PAR2 and GATA6 in HT55 and HT29 cells was analyzed by real time RT-PCR and Western blotting. The gene silence and gene over expression were employed to observe the effect of GATA6 on p53 expression in HT55 and HT29 cells.
RESULTS: The results showed that HT55 and HT29 cells expressed protease-activated receptor-2 (PAR2). Irradiation induced 38.6% HT55 cell and 33.8% HT29 cell apoptosis, which reduced to 4.2% and 5.6%, respectively after activation of PAR2. Exposure to irradiation increased the expression of GATA6; the latter played a critical role in suppression of p53 expression in HT55 and HT29 cells. Inhibition of GATA6 significantly increased the effect of irradiation on HT55 and HT29 cells.
CONCLUSIONS: Activation of PAR2 compromises the effect of irradiation on inducing colorectal cancer cell apoptosis, which can be prevented by inhibition of GATA6 expression.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Colorectal cancer; GATA binding protein 6; Irradiation; Protease-activated receptor-2

Mesh:

Substances:

Year:  2014        PMID: 24887481     DOI: 10.1016/j.abb.2014.05.021

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.

Authors:  Li Deng; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Authors:  Imen Nasri; Delphine Bonnet; Bailey Zwarycz; Emilie d'Aldebert; Sokchea Khou; Raoudha Mezghani-Jarraya; Muriel Quaranta; Corinne Rolland; Chrystelle Bonnart; Emmanuel Mas; Audrey Ferrand; Nicolas Cenac; Scott Magness; Laurianne Van Landeghem; Nathalie Vergnolle; Claire Racaud-Sultan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-16       Impact factor: 4.052

3.  Proteinase-activated receptor-2 enhances Bcl2-like protein-12 expression in lung cancer cells to suppress p53 expression.

Authors:  Guoyuan Ma; Chao Wang; Baoyu Lv; Yuanzhu Jiang; Lei Wang
Journal:  Arch Med Sci       Date:  2019-08-02       Impact factor: 3.318

Review 4.  The Clinical Significance and Mechanisms of REG4 in Human Cancers.

Authors:  Junyan Zhang; Zhi Zhu; Zhifeng Miao; Xuanzhang Huang; Zhe Sun; Huimian Xu; Zhenning Wang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability.

Authors:  Junfeng Sun; Hangyuan Zhou; Xingqi Bao; Yue Wu; Haowei Jia; Hongchao Zhao; Guanghui Liu
Journal:  Stem Cells Int       Date:  2021-11-23       Impact factor: 5.443

6.  The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.

Authors:  Sara Pessina; Gabriele Cantini; Dimos Kapetis; Emanuela Cazzato; Natalia Di Ianni; Gaetano Finocchiaro; Serena Pellegatta
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.